Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial

BACKGROUND: Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects. Subcutaneous injections of botulinum toxin type A are a promising treatment opt...

Full description

Saved in:
Bibliographic Details
Published in:Trials
Main Authors: Burmeister, Jan, Holle, Dagny, Bock, Eva, Ose, Claudia, Diener, Hans-Christoph, Obermann, Mark
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Study Protocol
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669653/
https://ncbi.nlm.nih.gov/pubmed/26634453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-1052-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items